Home›Research›Compare›Argireline vs PTD-DBM
Peptide Comparison
Argireline vs PTD-DBM
Both are Skin & Joint peptides.
Argireline
Acetyl Hexapeptide-3
Half-life: N/A (topical)
18 providers listed
Quick Verdict
Argireline
Risk
PTD-DBM
Risk
Side-by-Side Comparison
About Argireline
Inhibits SNARE complex formation in facial muscles; reduces acetylcholine release locally; relaxes expression lines without systemic effects
A topical peptide that reduces the appearance of expression lines by mimicking botulinum toxin's mechanism locally. Popular cosmeceutical ingredient.
Research Areas
About PTD-DBM
Contains a protein transduction domain enabling intracellular delivery. Disrupts Dishevelled-Axin protein interaction, preventing β-catenin degradation and activating Wnt target genes essential for hair follicle cycling and new follicle neogenesis.
A cell-penetrating peptide that activates Wnt/β-catenin signaling in hair follicle dermal papilla cells. Studied as a potential hair regeneration therapy acting through a mechanism distinct from minoxidil and finasteride.
Research Areas
Find Providers
Where to source these peptides
Providers offering
Argireline
18 listed
Browse directory →
Providers offering
PTD-DBM
7 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More skin joint Comparisons
Browse all peptides →Educational research tools — not medical advice.